TrialPharmacoEconomics1996

Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.

A Pelc et al.PubMed ↗Publisher ↗

No numbers read from the abstract.